Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Moscow accuses Berlin of stifling the opposition14.11.2025 - 2Vote In favor of Your #1 Method for diminishing Pressure01.01.1
- 3High Court freezes government move to shutter Army Radio pending ruling28.12.2025
- 4Thousands of Walgreens nasal spray bottles recalled. See which ones.26.11.2025
- 5Day to day Temporary Positions That Compensate Fairly in the US05.06.2024
- Which Startup's Innovation Could Reform Medical care?
- Exploring the Mind boggling Universe of Connections: Individual Bits of knowledge
- Instructions to Grasp the Innovation Behind 5G Pinnacles\
- Find the Lively Food Markets of South America
- Parents search for children missing since a volcanic eruption in Colombia 40 years ago
- Nations for Rock Climbing
- Parents who delay baby's first vaccines also likely to skip measles shots
- PHOTO ESSAY: Scientists trying to unravel one of the body's biggest mysteries
- Find Serenity: 10 Stunning Setting up camp Areas
